Publication: 321

Publication: 321

A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Clin Cancer Res vol 18 (2) 577-584

Year:: 2012
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No
Book Volume:: 1

Parents:: 621 707
Children:: None

Program:: TRP
Primary Committee:: PPP
Sec. Committees:

Pharmas:
Grants:: CA33601, U01 GM061393, U10 CA033601, T32 MH200065-06, CA60138, K07 CA140390, K07 CA140390-01, K24 CA113755, K07-CA140390-01, U01 GM61393, 5K24-CA113755

Corr. Author:
Authors:: Federico Innocenti Kouros Owzar Nancy L. Cox Patrick Evans Michiaki Kubo Hitoshi Zembutsu Chen Jiang Donna Hollis Taisei Mushiroda Liang Li Paula Friedman Liewei Wang Dylan Glubb Herbert Hurwitz Kathleen M. Giacomini Howard L. McLeod Richard M. Goldberg Richard L. Schilsky Hedy L. Kindler Yusuke Nakamura Mark J. Ratain

Networks:

Study: CALGB-151006
Multiple Studies, or Legacy Studies in Alliance Study:: CALGB-80303
Phases:: N/A, 3

Keywords:: GWAS, pharmacogenetics, bevacizumab, pancreatic cancer, gemcitabine